Study guide
2.2 Risk Factors for Substance Use Disorders
IC&RC Alcohol and Drug Counselor ADC
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Applying, Scoring, and Retakes
2 Domain I: Addiction Science
2.1 Neurobiology of Addiction 2.2 Risk Factors for Substance Use Disorders 2.3 Stages and Patterns of Substance Use Disorders
3 Domain I: Pharmacology Foundations
3.1 Drug Classifications, Interactions, and Cross-Tolerance 3.2 Intoxication and Overdose 3.3 Withdrawal Syndromes
4 Domain I: Major Substances
4.1 Alcohol 4.2 Sedative-Hypnotics and Benzodiazepines 4.3 Stimulants 4.4 Opioids
5 Domain I: Other Substances and Co-Occurring Conditions
5.1 Cannabis, Hallucinogens, Dissociatives, Inhalants, and Nicotine 5.2 Physiological, Psychological, and Social Effects 5.3 Co-Occurring Mental Health Conditions 5.4 Co-Occurring Medical Conditions
6 Domain II: Screening and Interviewing
6.1 Assessment Interviewing Techniques 6.2 Motivational Interviewing in Screening and Assessment 6.3 Brief Screening Instruments 6.4 Comprehensive Assessment Instruments
7 Domain II: Diagnosis and History
7.1 Drug and Alcohol Testing 7.2 DSM-5-TR Substance Use Disorder Criteria 7.3 Specifiers, Severity, and Differential Diagnosis 7.4 Biopsychosocial History and Collateral Sources
8 Domain II: Needs and Placement
8.1 Immediate and Ongoing Needs 8.2 ASAM Assessment Dimensions 8.3 ASAM Levels of Care and Placement
9 Domain III: Communication, Rapport, and Crisis
9.1 Communication and Learning Styles 9.2 Building Rapport 9.3 Reviewing Patterns and Methods of Use 9.4 Crisis Response and De-escalation
10 Domain III: Case Management and Populations
10.1 Referrals, Case Management, and Resources 10.2 Youth and Pregnancy 10.3 LGBTQ+, Justice-Involved, and Housing-Insecure Clients 10.4 Multidisciplinary Collaboration and Family Supports
11 Domain III: Trauma, Change, and Treatment Planning
11.1 Trauma and the Client 11.2 Vicarious Trauma and Counselor Burnout 11.3 Ambivalence, Resistance, and Feedback 11.4 Treatment Planning
12 Domain III: Groups, Discharge, and Recovery Pathways
12.1 Group Curriculum and Process 12.2 Group Dynamics and Cohesiveness 12.3 Discharge Planning and Termination 12.4 Multiple Pathways of Recovery including MAT
13 Domain IV: Boundaries and Scope
13.1 Dual Relationships 13.2 Self-Disclosure and Self-Awareness 13.3 Scope of Practice 13.4 Conflicts of Interest
14 Domain IV: Culture, Equity, and Rights
14.1 Multicultural Perspectives 14.2 Diversity, Inclusion, and Equity in Care 14.3 Client and Patient Rights
15 Domain IV: Documentation and Privacy
15.1 Documentation and Record Storage 15.2 42 CFR Part 2 Confidentiality 15.3 HIPAA and Privacy Intersections
16 Domain IV: Consent, Supervision, and Grievances
16.1 Informed Consent 16.2 Supervision and Consultation 16.3 Client Grievances
2.2 Risk Factors for Substance Use Disorders
Key Takeaways Explain This Topic AI
NIDA estimates that genes, including epigenetic effects of environment on gene expression, account for about 40–60% of a person's risk of addiction; family history is a clinical flag, not a sentence
Trauma and adverse childhood experiences (ACEs) raise SUD risk through toxic stress effects on brain development, immune function, and stress-response systems (CDC ACE framework)
Peers, home substance use, community availability, untreated mental illness, and early age of first use each add risk; no single factor decides the outcome
Protective factors — parental monitoring, refusal skills, positive relationships, school connection, and neighborhood resources — reduce risk and are as testable as risk factors
ADC Domain I Task B asks counselors to identify these risks in a history; it does not ask for a genetic test or a claim that trauma 'causes' every SUD
Last updated: September 2026
Task B: risk is plural, not a single cause
Domain I Task B asks counselors to identify risk factors for developing substance use disorders , with the candidate guide's examples including trauma and family history. That pairing is a hint, not a closed list. NIDA's science-of-addiction materials treat risk as stacked: biology, development, home, peers, school, neighborhood, mental health, and age of first use. The more risk factors a person carries, the greater the chance that use will become a disorder. Protective factors work in the opposite direction. No single factor determines the outcome, and a high-risk history is not a diagnosis.
On the exam, Task B items usually look like a short history. Your job is to name the risk (or the protective factor) the stem actually shows, not to invent a hidden trauma or to treat genes as destiny.
Family history and genetics — attribute the 40–60% figure to NIDA
Substance use disorders run in families for two overlapping reasons: shared genes and shared environments (what is modeled at the table, what is in the cabinet, what is normalized). Twin, family, and adoption studies are the classic methods for separating those strands.
NIDA states that genes, including the effects environmental factors have on a person's gene expression, called epigenetics, account for between 40 and 60 percent of a person's risk of addiction . That sentence is the source to cite when an item or a study-guide question asks for the commonly taught heritability range. It is not a claim that 40–60% of people with a family history will develop an SUD, and it is not a claim that 40–60% of any one client's disorder is 'the gene portion' you can point to on a lab slip. Heritability is a population statistic. For a given client it means: family history is a substantial biological risk factor, and environment still writes on top of it.
Epigenetics matters clinically because it blocks the false split between 'born that way' and 'just the neighborhood.' Stress, trauma, nutrition, and drug exposure can change how genes are expressed without changing the DNA sequence. A client can inherit vulnerability and have that vulnerability amplified by household chaos.
Worked vignette: Maya, 22, has two parents with alcohol use disorder. She has never used alcohol. Family history raises her risk; it does not assign her a diagnosis. The counselor documents the history, teaches that risk is not fate, and builds protective structure (monitoring, alternative peers, delay of first use) rather than waiting for a problem to 'show up in the blood.'
Exam trap: an option that says addiction is 100% genetic, or 0% genetic and only social learning, is wrong. NIDA's range sits in the middle, and it explicitly includes gene–environment interplay.
Trauma and adverse childhood experiences (ACEs)
Trauma is an event or series of events experienced as physically or emotionally harmful or life-threatening, with lasting effects on functioning. For SUD risk, the mechanisms counselors need are practical: trauma can drive use as self-medication, can dysregulate stress systems that later interact with the same circuits Task A described, and can cluster with other risks (unstable housing, family substance use, school failure).
Adverse childhood experiences (ACEs) are a specific, widely used way to talk about potentially traumatic events in childhood (ages 0–17) plus household conditions that undermine safety, stability, and bonding. The original ACE study (Felitti, Anda, and colleagues, with CDC and Kaiser Permanente) grouped experiences such as abuse, neglect, and household challenges (for example, household substance use, mental illness, or incarceration). CDC's current ACE framing still treats those examples as a core set, not as the only adversities that matter. Food insecurity, homelessness, and community violence can also load the stress system.
CDC reports that ACEs are common: three in four high school students reported one or more ACEs, and one in five reported four or more. Emotional abuse, physical abuse, and living in a household affected by poor mental health or substance use were among the most common in that youth data. CDC also notes that preventing ACEs could substantially reduce later prescription pain-medication misuse and other behavioral-health outcomes — a prevention statistic, not a claim that every person with ACEs will misuse opioids.
Toxic stress is the prolonged activation of stress-response systems without adequate buffering relationships. CDC links toxic stress from ACEs and under-resourced community conditions to effects on brain development, immune function, and stress-response systems — including attention, decision-making, and learning. Those are the same self-control and reward systems Domain I Task A asked you to map. Trauma is not a separate planet from neurobiology; it is one of the environmental forces that sculpts those circuits.
Worked vignette: Luis, 19, started using cannabis at 13 after witnessing domestic violence and living with a parent who drank daily. The stem gives you at least three Task B flags: trauma/ACEs, household substance use, and early onset. Do not collapse them into one word. Name them, because treatment planning later will need trauma-informed care and a substance-specific plan.
Exam traps:
An ACE score is a risk indicator , not a DSM diagnosis and not proof of current SUD.
Household substance use is an ACE-type household challenge; it is not 'only modeling.'
Trauma does not mean every client must have a flashback-heavy PTSD presentation. Many high-ACE histories show as irritability, academic failure, or 'I just like to party.'
Peers, home, school, and neighborhood
NIDA groups environmental risk in ways that match what counselors actually hear in an intake:
Home and family. Parents or older family members who use drugs, misuse alcohol, or break the law raise children's risk of later drug problems. Lack of parental supervision is a listed risk; parental monitoring and support are protective.
Peers and school. In adolescence, friends who use can pull even a low-biological-risk teen into first use. Poor social skills and school struggle add risk. School anti-drug policies and good grades are on NIDA's protective side of the table.
Community. Availability of drugs, community poverty, and thin neighborhood resources raise risk; neighborhood resources protect.
A common exam mistake is to treat 'peer pressure' as a teenage-only cartoon. Adults have peers too: a construction crew that drinks at 6 a.m., a partner who uses, a recovery house roommate who is still dealing. Environment does not stop at age 18.
Mental health conditions
NIDA notes that teens and people with mental disorders are at greater risk of drug use and addiction than others. The relationship runs both ways: untreated depression, anxiety, ADHD, PTSD, and psychotic disorders can precede use (self-medication, impulsivity, social isolation), and substance use can worsen or mimic psychiatric symptoms. Domain I Task E will go deeper on co-occurring mental health signs. For Task B, the testable point is that a psychiatric history is a risk factor for SUD , not a reason to skip the substance assessment or to assume the substance problem is 'only the depression.'
Counselor move in a vignette: if the client has panic attacks and daily benzodiazepine use, document both. Do not pick an option that says mental health risk 'doesn't count' because the presenting problem is a drug charge.
Early onset
NIDA is direct: taking drugs at any age can lead to addiction, but the earlier people begin, the more likely they are to develop serious problems. Two mechanisms are taught together. First, drugs hit a brain that is still wiring the prefrontal cortex — the braking system from Task A. Second, early use often travels with other risks (unstable home, abuse, genes, mental illness). Even so, early use itself is a strong marker of problems ahead.
Age 14 versus age 24 first use is not a moral comparison. It is a developmental one. An item that offers 'early onset is irrelevant if the family is loving' is a distractor. Love is protective; it does not cancel a 13-year-old's open prefrontal cortex.
Route of administration is a related accelerator NIDA lists with other risk factors: smoking or injecting a drug reaches the brain within seconds and raises addictive potential compared with slower oral routes. That detail overlaps later pharmacology chapters; on a Task B item it is still a risk amplifier, not a separate disease.
Protective factors — equally testable
Risk-factor questions sometimes hide the correct answer on the protective side of the table. NIDA's examples include self-efficacy (belief in self-control), parental monitoring and support, positive relationships, good grades, school anti-drug policies, and neighborhood resources. CDC's ACE work emphasizes safe, stable, nurturing relationships and environments as buffers against toxic stress.
Domain Raises SUD risk Protects against SUD risk
Biology Family history; NIDA-cited ~40–60% genetic/epigenetic contribution; some mental disorders No 'anti-gene,' but delayed first use and untreated-illness care reduce expression of risk
Trauma / ACEs Abuse, neglect, household substance use or violence; toxic stress Buffering adults; later trauma-informed supports
Family Poor supervision; family criminal involvement Monitoring, consistent support
Peers / school Using peers; school failure; drug availability at school Refusal skills, connection, anti-drug school climate
- Community Poverty, high availability, thin resources Neighborhood resources and opportunity
- Development Early onset; adolescent PFC immaturity Delayed initiation
Worked vignette: A 16-year-old with a parent in recovery, a coach who notices absences, and friends who do not use has family history (risk) stacked against monitoring and prosocial peers (protection). Task B is asking you to see both columns, not to declare the teen doomed or immune.
Remember: identifying risk is not the same as diagnosing SUD (Domain II) and not the same as choosing a level of care (ASAM placement). Task B is the 'who is more vulnerable, and why' layer of Domain I's 25% scientific slice.